Allergy Therapeutics

Allergy Therapeutics was founded in 1999 and is headquartered in Worthing, United Kingdom, an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminum-free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third-party products from its subsidiaries in European countries and via distribution agreements in additional countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in preclinical development.